CosmicTaco

Ataraxis AI Raises $20M for Personalized Cancer Treatment

CosmicTaco · 2025-03-06T10:24:30.154719+05:30

- Ataraxis AI, a New York-based startup, is revolutionizing cancer care with AI-driven personalized treatment plans. - The startup's technology predicts cancer outcomes, helping to avoid unnecessary chemotherapy and its side effects. - Ataraxis AI has raised $20.4 million in Series A funding to launch its first commercial test for breast cancer. - The AI model, trained on millions of images, is 30% more accurate than current standards in predicting breast cancer outcomes. - Co-founded by Jan Witowski and Krzysztof Geras, Ataraxis aims to impact half of new cancer cases by 2030. Source: [TechCrunch](https://techcrunch.com/2025/03/05/not-all-cancer-patients-need-chemo-ataraxis-ai-raised-20m-to-personalize-treatment/)

Ataraxis AI, a New York-based startup, is revolutionizing cancer care with AI-driven personalized treatment plans.
The startup's technology predicts cancer outcomes, helping to avoid unnecessary chemotherapy and its side effects.
Ataraxis AI has raised $20.4 million in Series A funding to launch its first commercial test for breast cancer.
The AI model, trained on millions of images, is 30% more accurate than current standards in predicting breast cancer outcomes.
Co-founded by Jan Witowski and Krzysztof Geras, Ataraxis aims to impact half of new cancer cases by 2030.

Source: TechCrunch